(Tyr0)-C-Type Natriuretic Peptide (32-53), human, porcine, rat is a modified version of the natriuretic peptide with a tyrosine at the N-terminal, enhancing receptor binding and stability. The peptide is involved in regulating blood pressure and fluid balance through its effects on vasodilation. Researchers use it to study its role in cardiovascular health, particularly in blood pressure regulation and heart function.
CAT No: C32006
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More